Medical devices safe, but could be safer with better regulation

nt and enforce standards more like those used for drug recalls.

"We suggest a federal mandate that recall notices be sent to all physicians who may use a device to help ensure that future recalls are handled expeditiously and the safety of medical devices is maximized," said study senior author Trish Perl, M.D., associate professor of medicine and director of hospital epidemiology and infection control at Johns Hopkins.

Outbreaks such as the one at Johns Hopkins have led patients and physicians to question the safety of bronchoscopy. The authors believe that the procedure is safe, but new standards to test and review the design of instruments before they are used in patients may help ensure safety, said Srinivasan.

At Johns Hopkins, the review showed that 414 patients underwent bronchoscopy during the outbreak; 48 respiratory tract and bloodstream infections were identified among 39 of these patients. P. aeruginosa was recovered in 32 infections, and exposure to a potentially contaminated bronchoscope may have had a role in the deaths of three critically ill patients. When the three contaminated bronchoscopes were identified and removed from service, P. aeruginosa levels returned to normal.


Contact: Trent Stockton
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
2. LA BioMed Medical/Research Briefs, July/August 2004
3. Medical implants work better when you rough them up, study finds
4. Dartmouth Medical School awarded $9 million grant for genomics research
5. University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
6. European Society for Medical Oncology Cancer Conference
7. Medical students inadequately prepared for clinical rotations, caring for chronically ill
8. Harvard Medical School launches new department to study human biology at the level of whole systems
9. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
10. Univ. of Pittsburgh Medical Center leads group buying PPLS cloning, stem cell business
11. Dartmouth Medical School geneticists discover new role for antisense RNA

Post Your Comments:

(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
Cached News: